Ultragenyx Pharmaceutical Inc. is covered by the following analysts.
| Firm | Analyst Name |
|---|---|
|
Baird
|
Joel L. Beatty, MD, CFA
|
|
Barclays
|
Gena Wang, Ph.D.
|
|
Bank of America Securities
|
Tazeen Ahmad
|
|
Canaccord Genuity
|
Whitney Ijem
|
|
Citi Research
|
Yigal Nochomovitz, Ph.D.
|
|
Credit Suisse
|
Tiago Fauth
|
|
Evercore ISI
|
Liisa Bayko
|
|
Goldman Sachs
|
Salveen Richter
|
|
Guggenheim Securities
|
Debjit Chattopadhyay
|
|
H.C. Wainwright Co.
|
Ed Arce
|
|
J.P. Morgan
|
Anupam Rama
|
|
Jefferies LLC
|
Maury Raycroft, Ph.D.
|
|
Morgan Stanley
|
Jeffrey Hung
|
|
Piper Sandler
|
Christopher Raymond
|
|
Stifel
|
Dae Gon Ha, Ph.D.
|
|
SVB Securities
|
Joseph P. Schwartz
|
|
TD Cowen
|
Yaron Werber, M.D.
|
|
Truist Securities
|
Joon Lee, M.D., Ph.D.
|
|
Wedbush Securities
|
Laura Chico, Ph.D.
|
Ultragenyx Pharmaceutical Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Ultragenyx Pharmaceutical Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Ultragenyx Pharmaceutical Inc. or its management. Ultragenyx Pharmaceutical Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.